See a Demo

Transparent Thinking Blog

TrialAssure cubes divider
Is Now the Time for Pharma and Biotech to Act with AI or Should the Industry Wait for a Better Model? The integration of artificial intelligence (AI) into pharmaceutical and biotechnology workflows has accelerated significantly in recent years. According to peer-reviewed research by the Tufts Center for the Study of Drug Development, et al, more than 65 percent of pharmaceutical and biotechnology companies, contract research organizations (CROs), and data and technology vendors servicing drug developers are piloting or actively using AI tools. However, more than one-third of organizations remain cautious, unsure whether current AI capabilities are mature enough to justify investment or wide-scale adoption. To address these concerns, we spoke with Zach Weingarden, Director of AI Technology and Applications at TrialAssure, about the risks of waiting, the realities of today’s tools, and how to start effectively.

Is Now the Time for Pharma and Biotech to Act with AI or Should the Industry Wait for a Better Model? 

by Zach Weingarden | October 2025

Posted in Blog
Read More
TrialAssure & Certara Joint Webinar: Authoring Clinical Documents with Downstream Regulatory Requirements in Mind

New Webinar Announced on Stronger Clinical Document Authoring Workflows with Certara & TrialAssure

by Don McLean | September 2025

Posted in Blog, News
Read More
AI in Drug Development

TrialAssure’s Zach Weingarden Joins Other Pharmaceutical Industry Leaders to Present on the Future of AI in Drug Development at RAPS Convergence 2025

by Don McLean | August 2025

Posted in Events, News
Read More
Scalable Medical Writing AI

The First Step Toward Scalable Medical Writing AI

by Don McLean | July 2025

Posted in Blog
Read More
Design for Transparency

What Sponsors Gain by Embracing the Design for Transparency Concept

by Don McLean | July 2025

Posted in Blog
Read More
AI for clinical trial registration using TrialAssure REGISTRY

TrialAssure Enhances REGISTRY Platform with AI-Powered Protocol Parsing to Streamline Global Clinical Trial Registration

by Don McLean | June 2025

Posted in Blog, News
Read More
GenAI That Works: How Partnerships Outperform Internal Builds in Pharma | TrialAssure

Why Internal GenAI Builds in Pharma Often Fall Short

by Don McLean | June 2025

Posted in Blog
Read More
Building a Data Sharing Mindset with 5 Steps to Streamline Anonymization Early in Clinical Trials TrialAssure

Building a Data Sharing Mindset with 5 Steps to Streamline Anonymization Early in Clinical Trials 

by Don McLean | May 2025

Posted in Blog
Read More
DIA Europe 2025

AI Takes Center Stage at DIA Europe 2025 in Basel

by Staff Writer | May 2025

Posted in Blog
Read More
A Clear Path to Successful AI Adoption in Medical Writing with Structured GenAI Pilots

Upcoming Webinar: A Clear Path to Successful AI Adoption in Medical Writing with Structured GenAI Pilots

by Don McLean | May 2025

Posted in Blog, Events
Read More
Get in Touch

Looking to streamline your clinical trial disclosure and transparency efforts?

TrialAssure is ready to help your organization embark on a Transparency Transformation!

To learn more about the TrialAssure Transparency Suite, specific products, or our company, contact us below.

Yes, please send me more information about TrialAssure.